Navigation Links
New Data Establishes Image Guided Treatment Option for Prostate Cancer as an Alternative to Surgery by Reducing Recovery Times and Lower Side Effects
Date:12/2/2015

CHICAGO, Dec. 2, 2015 /PRNewswire/ -- An analysis of clinical data from over 200 patients treated by Dr. Michael Stehling found that a new procedure that uses MR and ultrasound to guide treatment to the precise tumor location allows for faster recovery times and lower side effects in all stages of prostate cancer. Data found that the most common side effects are either eliminated or greatly reduced using image guided treatment. The study which was conducted at the Prostata Center of Offenbach, Germany (www.prostate-center.org) will be presented today at the annual meeting of the Radiological Society of North America (RSNA).

"The patients we have treated at The Prostata Center have had their cancers destroyed without the need for surgery, with a low incidence of side effects and in most cases have been back on their feet the next day," said Dr. Michael K. Stehling, an internationally recognized expert on image guided tumor ablation treatments and primary author of the study. "The data from this study confirms what we see every day, we have a very attractive approach for patients who are concerned about quality of life challenges and are considering options for the treatment of localized and late stage prostate cancer," he said.

Dr. Stehling has treated the most prostate cancer patients in the world using this image guided treatment, while generating the best therapeutic results. At the Prostata-Center which he founded in 2010, Stehling has treated hundreds of patients at every grade and stage of prostate cancer, and helped to advance the use of image guided treatment technologies. Dr. Stehling is a German Professor of Radiology, a former Associate Professor at Boston University and served as Research Assistant to Sir Peter Mansfield, Prof of Physics and Nobel Prize winner in Medicine in 2003 (for discoveries concerning magnetic resonance imaging).

Unlike other treatment procedures for prostate cancer therapy, image guided or irreversible electroporation (IRE) only destroys cells; vital tissue structures are not affected, making IRE the first tissue-selective form of therapy. IRE uses strong electric fields that cause cells to die without exposing the tissue to radiation or heat. IRE is precision guided and reliably destroys cells within the treatment field, but important anatomical structures in and around the prostate such as nerves, the intestinal wall, the sphincter, veins and arteries are spared. Potential issues with erection and bladder control and other side effects are reduced while healing time is minimal, making it an ideal method for focal prostate cancer therapy and for men concerned about quality of life challenges.

For the study, Dr. Stehling and his team of researchers evaluated data from 265 patients with primary (stages T1-T4) and recurrent PCa after surgery, radiation therapy and HIFU. Initial tumor control was achieved in all patients, and during the follow-up period of up to 4 years, the recurrence rates were 0/55 (Gleason <7), 3/117 (Gleason 7) and 10/67 (Gleason >7). There were no IRE-related complications and toxicity was extremely low: 27 patients reported a transient reduction of erectile function (EF) (resolved after 6-8m), 15 a permanent reduction and 2 a permanent loss of EF.

Throughout the study, there were no cases of IRE-related incontinence, even when the lower urinary sphincter was included in the treatment field. Incontinence is one of the most common adverse side effects of current treatments for localized prostate cancer and can have a substantial impact on the quality of life. The IRE treatment also had very low toxicity on the rectum and bladder, even in cases of advanced cancer infiltrating these structures in patients who were not candidates for surgery or radiation therapy anymore.

"Treating prostate cancer with minimal pain and minimal risk of impotence and incontinence, even in patients with advanced and recurrent cancer, with a one-time, one-day treatment, until recently, was unthinkable," Dr. Stehling said. "The cutting edge technology of IRE makes this a reality."

Co-Authors of the study include: E Guenther, DIPLPHYS; N Klein, MSc; S Zapf; D Kim, MD; B Rubinsky, PhD


'/>"/>
SOURCE The Prostata Center
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. Winterhawk Consulting Establishes Partnership with Onapsis Inc to expand their SAP security offerings using Onapsis X1.
2. PA Governor Corbett: Americure Rx Establishes Operations in Lehigh Valley; Creates 51 Jobs
3. Texas Childrens Hospital establishes the Jeffrey Modell Diagnostic & Research Center with a donation from the Jeffrey Modell Foundation
4. Quantum Materials Establishes Milestone as First Company to Deliver Tetrapod Quantum Dot Samples to LCD Display Manufacturer
5. Luoxis Establishes Study Collaborations with Two Research Centers in Oxidative Stress
6. SRI International Establishes Metabolite Standards Synthesis Center for National Heart, Lung and Blood Institute
7. AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather
8. TNI BioTech, Inc. Establishes New Record Date for Spin-Off Stock Dividend of Cytocom, Inc. Shares
9. Quanta Establishes Medical Advisory Board of World-Leading Renal Experts
10. PHARMALEX GmbH Establishes U.S. Affiliate And Appoints Andrew S. Verderame To Lead U.S. Business Interests
11. Varian Establishes Local Entity in Algeria to Support Expansion in North Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare product ... training aide "cprCUBE" on Kickstarter. The device will educate ... cardiac arrests with better efficiency compared to the dated ... real-time feedback on efficacy of the compression for a ... has a goal to raise $5,000. ...
(Date:10/2/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ... LLC , and named its founder as Diplomat,s chief ... Tennessee , will operate under Diplomat subsidiary ... offerings for health care partners to include IT outsourcing, ... "In an interoperable world, technology delivers comprehensive insight ...
(Date:10/2/2017)... announces the European launch of their new low volume, high throughput ... Cambridge, U.K on October 4th. The new ... unprecedented speed and sensitivity while using far less sample volume through ... ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Southern ... and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice Frueh, ... cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU School ...
(Date:10/13/2017)... ... ... Apple Rehab Shelton Lakes , which specializes in the delivery of sub-acute ... of a disaster drill on October 3rd. , Apple Rehab participated with the Shelton ... well as the Connecticut Long Term Care Mutual Aid Plan (LTC-MAP). The LTC-MAP ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The Visiting ... Day Market. Featuring a collection of specialty vendors and unique items from across the ... and quality-focused health and wellness services offered by the VNA. The boutique will ...
(Date:10/13/2017)... Milford, NJ (PRWEB) , ... October 13, 2017 , ... ... weekend at scenic Alexandria Park in Milford, NJ. This free event, sponsored by ... and physical activity. The fun run is geared towards children of all ages; ...
(Date:10/13/2017)... ... 2017 , ... Talented host, actor Rob Lowe, is introducing ... new episode of "Success Files," which is an award-winning educational program broadcasted on ... subject in-depth with passion and integrity. , Sciatica occurs when the sciatic nerve ...
Breaking Medicine News(10 mins):